Virtual EFORT Congress - VEChybrid
Main Theme: Sustainable Professional Practice

VIRTUAL EFORT CONGRESS 2021 | GUIDE OF CORPORATE PARTNERS & SPONSORS

Nested Applications

VEC exhibitors

CORPORATE INFORMATION

Although the 22nd EFORT Annual Congress Vienna 2021 has been cancelled, we are pleased to leave here the links and information of our existing corporate partners and sponsors.

EFORT invites you to browse through the Guide of Corporate Partners and Sponsors of the VEChybrid 2021 which represents those EFORT clients that have committed to and confirmed their participation in the 2021 EFORT Annual Congress.

Information text

Please note that this page is currently under development enhancement to reflect the categories of sponsorship herein listed. 

EFORT Industry Database


REV-MED, Inc.

#306, Dream techno, 464, Dunchon-daero, Jungwon-gu,
13229 Seongnam-si, Gyeonggi-do
South Korea
Phone: +49 89 237 625-40
e-Mail: info@rev-med.com
About Us

REV-MED produces and markets the TriCell Biologic Separation & Concentration System.

The TriCell System is designed to separate autologous peripheral blood or bone marrow into its essential elements. The TriCell triple chamber technology allows for accurate customized control over the biologic. The physician can easily specify and control the final concentration and cellular constellation to meet the therapeutic demand.

Area of Business: Medical Industry
Category: Medical Devices
Number of Employees worldwide: 2-10 employees
Founded in: 2016
Products
No products found.
Please contact us by e-Mail to request a meeting.